Margaret Pax
Direktor/Vorstandsmitglied bei ALIMERA SCIENCES, INC.
Vermögen: 15 241 $ am 30.04.2024
Profil
Margaret A Pax is currently an Independent Director at Alimera Sciences, Inc., a Director at Bioporto, Inc., an Independent Director at Repligen Corp., and an Independent Director at Jellagen Pty Ltd.
Previously, she worked as a Director at Bioporto A, Vice President-Marketing at OmniSonics Medical Technologies, Inc., and Vice President-Business Development at Microchips Biotech, Inc. Ms. Pax holds an MBA from Harvard University, an undergraduate degree from the College of the Holy Cross (Massachusetts), and another MBA from Harvard Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REPLIGEN CORPORATION
0,00% | 18.03.2024 | 92 ( 0,00% ) | 15 241 $ | 30.04.2024 |
Aktive Positionen von Margaret Pax
| Unternehmen | Position | Beginn |
|---|---|---|
| ALIMERA SCIENCES, INC. | Direktor/Vorstandsmitglied | 08.11.2023 |
| REPLIGEN CORPORATION | Direktor/Vorstandsmitglied | 18.03.2024 |
| Bioporto, Inc. | Direktor/Vorstandsmitglied | - |
Jellagen Pty Ltd.
 Jellagen Pty Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Jellagen Pty Ltd. produces research grade functional non-mammalian collagen products. The company was founded by Andrew Mearns Spragg and Alex Muhlholzl in May 2013 and is headquartered in Pembroke Dock, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Margaret Pax
| Unternehmen | Position | Ende |
|---|---|---|
OmniSonics Medical Technologies, Inc.
 OmniSonics Medical Technologies, Inc. Pharmaceuticals: MajorHealth Technology OmniSonics Medical Technologies, Inc. developed medical catheter based thrombectomy device. It used to transverse ultrasound technology to remove thrombus and enhance the dispersion of physician specified fluids in the peripheral vasculature. The company was founded by Robert Rabiner and was headquartered in Lakewood, NY. | Vertrieb & Marketing | - |
| BIOPORTO A/S | Direktor/Vorstandsmitglied | - |
Microchips Biotech, Inc.
 Microchips Biotech, Inc. Pharmaceuticals: MajorHealth Technology Microchips Biotech, Inc. develops drug delivery systems and bio sensing devices. Its technologies are designed to transform electromechanical medical devices into highly tuned biochemical sensing and therapy systems. The company was founded by Terrance G. McGuire, Michael J. Cima, John T. Santini, Jr. and Robert S. Langer, Jr. in 1999 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Ausbildung von Margaret Pax
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| ALIMERA SCIENCES, INC. | Health Technology |
| BIOPORTO A/S | Health Technology |
| Private Unternehmen | 4 |
|---|---|
OmniSonics Medical Technologies, Inc.
OmniSonics Medical Technologies, Inc. Pharmaceuticals: MajorHealth Technology OmniSonics Medical Technologies, Inc. developed medical catheter based thrombectomy device. It used to transverse ultrasound technology to remove thrombus and enhance the dispersion of physician specified fluids in the peripheral vasculature. The company was founded by Robert Rabiner and was headquartered in Lakewood, NY. | Health Technology |
Microchips Biotech, Inc.
Microchips Biotech, Inc. Pharmaceuticals: MajorHealth Technology Microchips Biotech, Inc. develops drug delivery systems and bio sensing devices. Its technologies are designed to transform electromechanical medical devices into highly tuned biochemical sensing and therapy systems. The company was founded by Terrance G. McGuire, Michael J. Cima, John T. Santini, Jr. and Robert S. Langer, Jr. in 1999 and is headquartered in Lexington, MA. | Health Technology |
Jellagen Pty Ltd.
Jellagen Pty Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Jellagen Pty Ltd. produces research grade functional non-mammalian collagen products. The company was founded by Andrew Mearns Spragg and Alex Muhlholzl in May 2013 and is headquartered in Pembroke Dock, the United Kingdom. | Consumer Non-Durables |
| Bioporto, Inc. |
